Endo-Vac-Therapy for Post-Sleeve Gastrectomy Leaks
Endoscopic Negative Pressure Therapy for Post-sleeve Gastrectomy Proximal Staple Line Leaks
1 other identifier
observational
40
1 country
1
Brief Summary
Endoscopic negative pressure therapy (ENPT) is a safe technique, showing promising results in the treatment of leakages of the upper and lower gastrointestinal tract. The purpose of this study is to determine the safety and efficacy of ENPT in the management of proximal staple line leak after sleeve gastrectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2021
CompletedFirst Submitted
Initial submission to the registry
December 19, 2021
CompletedFirst Posted
Study publicly available on registry
January 12, 2022
CompletedJanuary 12, 2022
January 1, 2022
1.5 years
December 19, 2021
January 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with closure of staple line leak
Resolution of the fistula with no further need for intervention (surgical or endoscopic).
up to 16 weeks
Secondary Outcomes (3)
Number of endoscopic interventions
up to 16 weeks
Hospital stay
up to 24 weeks
Mortality
up to 24 weeks
Interventions
Endoscopic placement of a sponge in/at staple line leaks under negative pressure.
Eligibility Criteria
Patients older 18 years who underwent laparoscopic sleeve gastrectomy for morbid obesity and developed a proximal staple line leak within 30 days.
You may qualify if:
- Staple line leak detected by endoscopy and/or CT within 30 days after surgery.
- Age 18 years or older.
- Written informed consent.
You may not qualify if:
- Declined informed consent.
- Leaks detected later than 30 days after surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinikum Vest GmbH
Recklinghausen, North Rhine-Westphalia, 45657, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Markus Reiser, MD
Chief Dept. Medicine and Gastroenterology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Dept. Gastroenterology
Study Record Dates
First Submitted
December 19, 2021
First Posted
January 12, 2022
Study Start
January 3, 2020
Primary Completion
June 30, 2021
Study Completion
December 17, 2021
Last Updated
January 12, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share